Home Thiazoles 87691-87-0
87691-87-0,MFCD04117970
Catalog No.:AA003HWT
87691-87-0 | 3-(1-Piperazinyl)-1,2-benzisothiazole
Pack Size
Purity
Availability
Price(USD)
Quantity
  
1g
98%
in stock  
$15.00   $10.00
- +
5g
98%
in stock  
$26.00   $18.00
- +
25g
95%
in stock  
$93.00   $65.00
- +
100g
98%
in stock  
$286.00   $200.00
- +
500g
98%
in stock  
$1,143.00   $800.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Q & A
  • Technical Information
  • Properties
  • Literature
Technical Information
Catalog Number:
AA003HWT
Chemical Name:
3-(1-Piperazinyl)-1,2-benzisothiazole
CAS Number:
87691-87-0
Molecular Formula:
C11H13N3S
Molecular Weight:
219.3060
MDL Number:
MFCD04117970
IUPAC Name:
3-piperazin-1-yl-1,2-benzothiazole
InChI:
InChI=1S/C11H13N3S/c1-2-4-10-9(3-1)11(13-15-10)14-7-5-12-6-8-14/h1-4,12H,5-8H2
InChI Key:
KRDOFMHJLWKXIU-UHFFFAOYSA-N
SMILES:
N1CCN(CC1)c1nsc2c1cccc2
EC Number:
618-048-1
UNII:
59D8RAT1F9
Properties
Computed Properties
 
Complexity:
218  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
219.083g/mol
Formal Charge:
0
Heavy Atom Count:
15  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
219.306g/mol
Monoisotopic Mass:
219.083g/mol
Rotatable Bond Count:
1  
Topological Polar Surface Area:
56.4A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
2.1  

Synonyms
 
3-(1-Piperazinyl)-1,2-benzisothiazole 
87691-87-0 
CHEMBL1154 
FT-0082338 
FT-0601156 
FT-0650663 
P2064 
1-(1,2-BENZISOTHIAZOL-3-YL)PIPERAZINE 
BENZISOTHIAZOLE-3-YL-PIPERAZINE (BITP) 
C-5272 
EN300-230853 
691P870 
C-12075 
59D8RAT1F9 
I09-0600 
F0001-2180 
3-(1-Piperazinyl)-1,2-benzisothiazole, >=98% (HPLC) 
CHEMBL1204336 
C11H13N3S 
ACN-028538 
CID2772144 
A10446 
3-Piperazinyl-1,2-Benzisothiazole Hydrochloride 
3-(1-Piperazinyl)-1,2-benzisothiazole, 98% - 1G 1g 
3-piperazinylbenzo[d]isothiazole 
133070-64-1 
144010-02-6 
3-PIPERAZIN-1-YL-1,2-BENZISOTHIAZOLE 
3-Piperazino-1,2-benzisothiazole 
3-Piperazinyl-1,2-benzisothiazole 
3-piperazin-1-yl-1,2-benzothiazole 
3-Piperazin-1-yl-benzo(d)isothiazole 
3-(Piperazin-1-yl)benzo(d)isothiazole 
AK-30573 
3-(piperazin-1-yl)benzo[d]isothiazole 
3-PIPERAZIN-1-YLBENZO[D]ISOTHIAZOLE 
A1-00278 
W-205602 
MFCD04117970 
ZERO/005869 
Benzisothiazylpiperazine 
Ziprasidone related compound A free base 
ID-11614 
MJ-14069 
ACMC-209qpf 
3-Piperazin-1-yl-benzo[d]isothiazole 
benzisothiazole piperazine 
piperazinyl benzoisothiazole 
N-benzisothiazolylpiperazine 
AC1MCL06 
3-piperazinyl-benzisothiazole 
KSC447S9J 
SCHEMBL250876 
N-(3benzoisothiazolyl)piperazine 
CTK3E7994 
3-(1-Piperazinyl)benzisothiazole 
UNII-59D8RAT1F9 
3-piperazin-1-yl-benzisothiazole 
DTXSID70236556 
3-piperazinyl-1,2-benzisothiazol 
KRDOFMHJLWKXIU-UHFFFAOYSA-N 
N-(3-benzoisothiazolyl)piperazine 
N-(3-benzisothiazolyl) piperazine 
N-(3-benzisothiazolyl)-piperazine 
3-piperazinylbenzo [d] isothiazole 
ALBB-008924 
BB_SC-01607 
3-(piperazin-1-yl)-1,2-benzothiazole 
BCP17556 
EBD30248 
KS-000001MO 
ZINC2568290 
Ziprasidone hydrochloride monohydrate specified impurity A [EP] 
ZX-AN007819 
ZX-CM013436 
ANW-38881 
BBL012469 
BDBM50007695 
BITP 
CP-937 
CP0135 
SBB013748 
STK347701 
AKOS000301991 
AB20773 
AC-1868 
CS-W010470 
DS-1936 
GF-0131 
N-(3-Benzisothiazolyl)piperazine 
ID11614 
MCULE-1970805990 
QC-4340 
RP05122 
RTR-027577 
TRA0080216 
3-(1-piperazinyl)-I,2-benzisothiazole 
3-?1-piperazinyl?-1,2-benzisothiazole 
4-(1,2-benzisothiazol-3-yl)piperazine 
N-(1,2-benzisothiazol-3-yl)piperazine 
1,2-Benzisothiazole, 3-(1-piperazinyl)- 
1-(1,2-benzoisothiazol-3-yl)piperazine 
4-(1,2-benzisothiazole-3-yl)piperazine 
1-(1,2-benzisothiazol-3-yl) piperazine 
4-(1,2-benzisothiazol-3-yl)-piperazine 
AJ-41604 
AN-14536 
BAS 13031053 
BC210154 
CC-12154 
SC-16820 
4-(1,2-BENZISOTHIAZOL-3-YL)-1-PIPERAZINE 
1-(1,2-benzoisothiazol- 3-yl)piperazine 
AB0008308 
AX8013179 
BB0216394 
DB-006229 
ST2410338 
ST4128495 
TR-027577 
AM20060794 
BB 0216394 
Literature

Title: Synthesis and evaluation of a series of 2-substituted-5-thiopropylpiperazine (piperidine)-1,3,4-oxadiazoles derivatives as atypical antipsychotics.

Journal: PloS one 20120101

Title: Critical appraisal of lurasidone in the management of schizophrenia.

Journal: Neuropsychiatric disease and treatment 20120101

Title: Oral ziprasidone in the treatment of patients with bipolar disorders: a critical review.

Journal: Expert review of clinical pharmacology 20110301

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Additional Info:
Q & A